Search Results - "Cetta I"

OnabotulinumToxinA Reduces Pharmacological Burden in Chronic Migraine Patients: A Two-Center Prospective Cohort Study.

Authors: Montisano, Danilo Antonio Parisi, Alessandra Raggi, Alberto et al.

Source: Toxins. Mar2026, Vol. 18 Issue 3, p143. 11p.

Magnetic resonance spectroscopy during migraine attacks: A systematic review.

Authors: Radutiu, Delia-Ioana Szabo, Edina Christensen, Rune Häckert et al.

Source: Cephalalgia. May2026, Vol. 46 Issue 5, p1-15. 15p.

Insights from triggers and prodromal symptoms on how migraine attacks start: The threshold hypothesis.

Authors: Sebastianelli G Atalar AÇ Cetta I et al.

Corporate Authors: Sebastianelli G Atalar AÇ Cetta I et al.

Source: Cephalalgia : an international journal of headache [Cephalalgia] 2024 Oct; Vol. 44 (10), pp. 3331024241287224.

Publication Type: Journal Article; Review; Research Support, Non-U.S. Gov't

Journal Info: Publisher: Sage Country of Publication: England NLM ID: 8200710 Publication Model: Print Cited Medium: Internet ISSN: 1468-2982 (Electronic) Linking ISSN: 03331024 NLM ISO Abbreviation: Cephalalgia Subsets: MEDLINE

Clinical and neuroradiological evolution of thymoma-associated anti-GABAA receptor autoimmune encephalitis: insights from a clinical case report.

Authors: Palazzo L Cetta I Bongiovanni L et al.

Source: Journal of neurology [J Neurol] 2025 Oct 28; Vol. 272 (11), pp. 733. Date of Electronic Publication: 2025 Oct 28.

Publication Type: Letter

Journal Info: Publisher: Springer-Verlag Country of Publication: Germany NLM ID: 0423161 Publication Model: Electronic Cited Medium: Internet ISSN: 1432-1459 (Electronic) Linking ISSN: 03405354 NLM ISO Abbreviation: J Neurol Subsets: MEDLINE; In Process

Efficacy of galcanezumab in migraine central sensitizatio.

Authors: Danno, Daisuke Imai, Noboru Kitamura, Shigekazu et al.

Source: Scientific Reports. 9/18/2024, Vol. 14 Issue 1, p1-12. 12p.

A clinical guide for physiotherapists to assess and manage cervical musculoskeletal impairment and pain sensitivity in migraine patients.

Authors: Castaldo, Matteo Arendt-Nielsen, Lars Di Antonio, Stefano

Source: Journal of Manual & Manipulative Therapy (Taylor & Francis Ltd). Oct2025, Vol. 33 Issue 5, p412-429.

Brain imaging in migraine with and without aura: Similarities and differences.

Authors: Casillo, Francesco Sebastianelli, Gabriele Abagnale, Chiara et al.

Source: Cephalalgia. Sep2025, Vol. 45 Issue 9, p1-11. 11p.

Monthly Versus Quarterly Fremanezumab in Real Life: A Comparison of Effectiveness, Tolerability, and Adherence.

Authors: Muñoz-Vendrell, Albert Campoy, Sergio Cano Sánchez, Luis Miguel et al.

Source: Acta Neurologica Scandinavica. 8/21/2025, Vol. 2025, p1-10. 10p.

Subjects: Migraine, Treatment effectiveness, Monoclonal antibodies, Field research, Patient compliance

Overlap between perceived triggers, premonitory symptoms and symptom persistence across migraine phases: A REFORM study.

Authors: Thuraiaiyah, Janu Christensen, Rune H. Al-Khazali, Haidar M. et al.

Source: Cephalalgia. Aug2025, Vol. 45 Issue 8, p1-9. 9p.

Executive Functions, Anxiety, Social Participation and Quality of Life in Children with Migraine During COVID-19.

Authors: Genizi, Jacob Samet, Hila Zaitoon, Hussein et al.

Source: Life (2075-1729). Apr2025, Vol. 15 Issue 4, p528. 13p.

Migraine aura discrimination using machine learning: an fMRI study during ictal and interictal periods.

Authors: Fernandes Jr, Orlando Ramos, Lucas Rego Acchar, Mariana Calixto et al.

Source: Medical & Biological Engineering & Computing; Aug2024, Vol. 62 Issue 8, p2545-2556, 12p

Examining the ability of artificial intelligence with ChatGPT-4.0 to create an exercise program: Case scenario examples "lumbar disc herniation, chronic migraine, and urge urinary incontinence".

Authors: Onan, Dilara Arıkan, Halime Can, İrem et al.

Source: Turkish Journal of Kinesiology. 2025, Vol. 11 Issue 1, p28-44.

Evaluation of Subjective Visual Vertical (SVV) and Ocular Movements in Patients with Primary headache -An Analytical Cross-sectional Study.

Authors: Penumaka, Vijayalakshmi Das, Soumyajit Kalidoss, Vinoth Kumar et al.

Source: Indian Journal of Otolaryngology & Head & Neck Surgery (Springer Nature). Jan2025, Vol. 77 Issue 1, p334-341. 8p.

AUTHOR INDEX Volume 18.

Source: Mathematical Models & Methods in Applied Sciences. Dec2008, Vol. 18 Issue 12, p2175-2179. 5p.

Associations between premonitory symptoms and triggers in migraine: An exploratory study.

Authors: Ashraf, Usman Tomlinson, Susan E

Source: Cephalalgia Reports. 12/8/2025, Vol. 8, p1-11. 11p.

Biodistribution of atogepant and rimegepant in mouse peripheral and central structures of relevance to migraine pathogenesis.

Authors: Pistolesi, Alessandra De Cesaris, Francesco Buonvicino, Daniela et al.

Source: Cephalalgia. Nov2025, Vol. 45 Issue 11, p1-11. 11p.

Impact of migraine on quality of life and well-being among King Khalid University students: a cross-sectional study.

Authors: Ghazy, Ramy Mohamed Mohamed, Soso Shawky Al-Qahtani, Ali S. et al.

Source: Psychology, Health & Medicine. Oct2025, p1-20. 20p. 3 Illustrations.

Skin-Brain Axis: neural pathways in acupuncture treatment.

Authors: He, Teng Zheng, Yuanjia Yan, Jinglan et al.

Source: Chinese Medicine. 10/7/2025, Vol. 20 Issue 1, p1-21. 21p.

Migraine Trigger or Prodromal Symptom: Which Came First — the Chocolate or the Craving?

Source: Neurology Alert. Dec2024, Vol. 44 Issue 4, p1-14. 14p.

Blood pressure monitoring in elderly migraineurs starting an anti-CGRP monoclonal antibody: a real-world prospective study.

Authors: Mascarella, Davide Andrini, Giorgia Baraldi, Carlo et al.

Source: Neurological Sciences. Nov2024, Vol. 45 Issue 11, p5365-5373. 9p.

Subjects: Blood pressure, Older patients, Antihypertensive agents, Hypertension, Erenumab